"18F-flotufolastat is approved by the FDA for use in patients with suspected prostate cancer metastasis who are potentially curable by definitive surgery or radiation, and patients with suspected prostate cancer recurrence based on elevated PSA levels."
18F-flotufolastat PET alters treatmen... - Advanced Prostate...
18F-flotufolastat PET alters treatment approach for nearly 90% of patients with recurrent prostate cancer
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Testosterone slows prostate cancer recurrence in low-risk patients
years following surgery, they tested the patients for biochemical recurrence of the cancer, as...
When should I do my next PSMA scan to detect recurrent prostate cancer?
had a 18F-DCFPyl-PET/CT PSMA PET/MRI scan at NIH when my PSA was 0.5 and no cancer was detected....
Recurrent prostate cancer with ECE
yeatz (new member).
I have recurrence of cancer after EBRT and ADT. Cancer has gone outside the...
Stereotactic ablative radiotherapy for new recurrent prostate cancer nodule.
ablative radiotherapy for small local recurrent prostate cancer nodule? And if not successful still...
TURP for prostate cancer patients
it’s not for prostate cancer patients but for BHP (Benign prostatic hyperplasia) patients. They...
Related Posts
Antidepressant medication use and prostate cancer recurrence in men with depressive disorders. 
radiofrequency interstitial tumor ablation (RITA) for the focal treatment of patients with local prostate cancer recurrence.
Statin Drugs and Prostate Cancer recurrence
FDA Approves another PSMA PET scan for Prostate Cancer Imaging
fenbendazole treatment for Prostate cancer
